58,95 €
58,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
29 °P sammeln
58,95 €
58,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
29 °P sammeln
Als Download kaufen
58,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
29 °P sammeln
Jetzt verschenken
58,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
29 °P sammeln
  • Format: ePub

A brand-new title in the field of dermatology, Therapy for Severe Psoriasis provides the ultimate coverage of the treatment options available for today's most serious cases, including biologics and oral therapies. It features discussions of the newest drug therapies , recent FDA-approved biosimilars, and combination approaches to care, while an overview chapter was designed to aid those new to the field in understanding the nuances of difficult-to-treat subtypes of psoriasis. Comprehensive and focused, Therapy for Severe Psoriasis will be a welcome addition to the library of any dermatologist…mehr

Produktbeschreibung
A brand-new title in the field of dermatology, Therapy for Severe Psoriasis provides the ultimate coverage of the treatment options available for today's most serious cases, including biologics and oral therapies. It features discussions of the newest drug therapies, recent FDA-approved biosimilars, and combination approaches to care, while an overview chapter was designed to aid those new to the field in understanding the nuances of difficult-to-treat subtypes of psoriasis. Comprehensive and focused, Therapy for Severe Psoriasis will be a welcome addition to the library of any dermatologist seeking in-depth information on the challenges of this condition.

  • Each of the 16 chapters includes either an in-depth focus on a single therapy or an overview of a unique aspect of psoriasis, including: UVB therapy, methotrexate, acitretin, cyclosporine, apremilast, etanercept, infliximab, adalimumab, ustekinumab, secukinumab, and ixekizumab.
  • Takes an evidence-based approach to hard-to-treat severe psoriasis.
  • Discusses the newest drug therapies (such as ixekizumab), plus recent FDA-approved biosimilars, a topic unique to this particular psoriasis text.
  • Presents combination approaches for instances when standard treatments are not successful.
  • Includes an overview chapter to help beginners understand the nuances of the disorder.

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Mark G. Lebwohl, MD, FAAD
Chairman Emeritus
Kimberly and Eric J. Waldman Department of Dermatology
Dean for Clinical Therapeutics
Icahn School of Medicine at Mount Sinai
New York, NY, USA
Rezensionen
"gives a fine overview of the treatments available for patients with moderate to severe psoriasis"

"Therapy for Severe Psoriasis can serve as your go-to resource for a comprehensive understanding of therapies that are currently available."

"This is a useful reference for staying current on how to use biologics and other new drugs for severe psoriasis."

- Patricia Wong, MD (Private Practice) for Doody's Review Services